Indirect comparisons using single-arm trials in health technology assessment (GSK/ScHARR joint funded PhD studentship)
Dr J W Stevens
Dr K Ren
Dr J Hamilton
No more applications being accepted
Funded PhD Project (Students Worldwide)
Health technology assessment (HTA) is a multidisciplinary process to systematically evaluate the clinical, economic and broader impact of the use of a health technology. Evidence on clinical effectiveness can arise from multiple sources. In a hierarchy of study designs, randomised controlled trials are often considered to be the gold standard for evaluating a technology. Regulatory agencies may grant marketing authorisation on the basis of evidence from single-arm studies because it is unethical to randomise patients or difficult to recruit. Such lack of comparative evidence complicates economic evaluations used to assess which of several treatments should be adopted by a health care system. The need for indirect comparison methodology to assess relative treatment effects has led to the development of novel statistical methods and raised methodological challenges.
This research aims to explore methods for adjusting for biases and characterise uncertainty arising from the use of single-arm studies in economic models.
This PhD is jointly funded by GSK and the University of Sheffield. In addition to the supervisors from the University of Sheffield, staff from GSK will also be part of the supervisory team. You will be given the opportunity to spend time at GSK to gain work and research experience.
- Honours Bachelor degree (2.1 or above) in Mathematics or Statistics
- Master’s degree at Merit in Statistics or subject with high statistical content, OR equivalent experience
- English proficiency for non-UK candidates: IELTS with 7.0 overall (6.5 in each component). English proficiency can also be demonstrated by holding a degree from a majority English country obtained within the last five years.
How to Apply:
Please complete a University Postgraduate Research Application form using the ’Visit Website’ link below.
Please clearly state the title of the studentship, the prospective main supervisor (Dr John W Stevens) and select ScHARR as the department.
Please also include:
- a covering letter explaining why you wish to apply for this studentship
- a copy of your CV
Funding is provided by GlaxoSmithKline plc (GSK) and the University of Sheffield. The project start date will be agreed with the successful candidate.
Applications are open to UK, EU and Overseas candidates.
Applicants can choose between 3 year full time or 6 year part time study (dependent on visa regulations). Funding covers full tuition fees (Home, EU or Overseas), a quarterly stipend at the UKRI rate (currently £15,009 for the 2019/20 academic year), and a £750 per annum support grant to assist with research costs. These figures are adjusted on a pro-rata basis for part time study.